In Vitro Diagnostic R&D Solutions

Nucleic acid formulations include DNA, RNA, siRNA, and other nucleic acid molecules that deliver highly accurate diagnostic information by identifying specific genes or pathogens through unique nucleic acid sequences. By integrating advanced technology platforms with extensive industry experience, CD Formulation is dedicated to offering high-quality nucleic acid formulation solutions for the in vitro diagnostics (IVD) sector.

About In Vitro Diagnostics

In vitro diagnostics (IVD) encompass reagents, instruments, and systems utilized for the collection, preparation, and testing of samples (e.g., blood, urine, body fluids, and tissues) from the human body to identify and diagnose diseases and other medical conditions. IVDs play a crucial role in disease prevention, diagnostic assessment, treatment evaluation, therapeutic drug screening, health status assessment, and genetic prediction. Nucleic acid detection reagents are a specific category of IVDs that employ nucleic acid amplification detection technology. These reagents have been applied in various fields, including pathogen detection, early diagnosis of specific diseases, and identification of substances within the body.

Fig.1 Schematic diagram of in vitro diagnostics. (Zhang J J, et L., 2020)

Advantages of In Vitro Nucleic Acid Diagnostics

• The ability to detect target nucleic acid sequences at extremely low concentrations.
• Modern nucleic acid testing techniques, such as polymerase chain reaction (PCR) and sequencing, can process a large number of samples in a short period.
• Nucleic acid in vitro diagnostics are utilized in a wide range of applications, including screening for genetic diseases, diagnosing infectious diseases, and detecting tumor markers.

Our In Vitro Diagnostic R&D Solutions

CD Formulation integrates a diverse array of expertise and services in the field of in vitro diagnostic solutions for nucleic acid formulations. We are dedicated to developing and optimizing a comprehensive range of highly efficient and accurate diagnostic tools for our clients.

Real-Time Fluorescent Quantitative PCR Technology Development

We develop highly sensitive and specific real-time fluorescent quantitative PCR (qPCR) methods for the quantitative detection of nucleic acid-based drugs. This advancement contributes to the rapid detection and analysis of clinical samples, thereby enhancing diagnostic accuracy.

Targeted Capture Technology for Nucleic Acid Molecules Development

The introduction of efficient nucleic acid capture technologies, such as magnetic bead capture and nanomaterial-based capture methods, enables the precise isolation and detection of specific nucleic acid sequences from complex samples.

Isothermal Amplification Technologies Optimization

Optimization of isothermal amplification technologies for efficient nucleic acid amplification and detection, eliminating the need for complex equipment in resource-limited environments or for on-site testing.

CRISPR/Cas System Development

The CRISPR/Cas system is utilized to develop a rapid in vitro nucleic acid detection program based on CRISPR technology. By leveraging the high specificity of these systems, precise identification and detection of target nucleic acid sequences can be accomplished.

Nucleic Acid In Vitro Diagnostic Technology

Publication Data

CD Formulation's in vitro diagnostic solutions for nucleic acid formulations encompass the entire process, from sample collection and nucleic acid extraction to testing and results analysis. Contact us for tailored services from our team of professionals, designed to meet the diverse needs of our clients and ensure superior products and services in the IVD field.

How It Works

STEP 1

Submit a service request describing your specific research or development need.

STEP 2

We'll email you to provide your quote and confirm order details if applicable.

STEP 3

Execute the project with real-time communication, and deliver the final report promptly.